Wealth Enhancement Advisory Services, LLC Vertex Pharmaceuticals Inc Call Options Transaction History

Wealth Enhancement Advisory Services, LLC

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Oct 23, 2024	BUY	$460.0 - $505.78 $2.35 Million - $2.58 Million	5,100 New	5,100 $2.37 Million
Q1 2024 Apr 15, 2024	SELL	$407.69 - $446.08 $1.26 Million - $1.38 Million	-3,100 Reduced 68.89%	1,400 $585,000
Q4 2023 Jan 30, 2024	BUY	$343.0 - $410.68 $1.54 Million - $1.85 Million	4,500 New	4,500 $1.83 Million

1,723

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Wealth Enhancement Advisory Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Wealth Enhancement Advisory Services, LLC with notifications on news.